Activity monitors for increasing physical activity in adult stroke survivors by Lynch, EA et al.
Cochrane Database of Systematic Reviews
Activity monitors for increasing physical activity in adult
stroke survivors (Protocol)
Lynch EA, Borschmann K, Callisaya ML, Fini NA, Janssen H, Johnson L, Jones TM, Kramer S, Kuys
S, Mahendran N, Simpson DB, English C, on behalf of the ACTIOnS Collaboration
Lynch EA, Borschmann K, Callisaya ML, Fini NA, Janssen H, Johnson L, Jones TM, Kramer S, Kuys S, Mahendran N, Simpson DB, English C, on
behalf of the ACTIOnS Collaboration.
Activity monitors for increasing physical activity in adult stroke survivors.
Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD012543.
DOI: 10.1002/14651858.CD012543.
www.cochranelibrary.com
Activitymonitors for increasing physical activity in adult stroke survivors (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iActivity monitors for increasing physical activity in adult stroke survivors (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Protocol]
Activity monitors for increasing physical activity in adult
stroke survivors
Elizabeth A Lynch1,2,3, Karen Borschmann2 ,4,5, Michele L Callisaya6, Natalie A Fini5 ,7, Heidi Janssen2,8,9, Liam Johnson4 ,10, Taryn
M Jones11, Sharon Kramer4, Suzanne Kuys12, Niruthikha Mahendran13, Dawn B Simpson6 , Coralie English2,8,9, on behalf of the
ACTIOnS Collaboration14
1Sansom Institute for Health Research, University of South Australia, Adelaide, Australia. 2NHMRC Centre of Research Excellence in
Stroke Rehabilitation and Brain Recovery, Florey Institute of Neuroscience and Mental Health & Hunter Medical Research Institute,
Melbourne and Newcastle, Australia. 3NHMRC Centre of Research Excellence in Stroke and Brain Recovery, The Florey Institute
of Neuroscience and Mental Health, Melbourne, Australia. 4Stroke Division, Florey Institute of Neuroscience and Mental Health,
Melbourne, Australia. 5School of Allied Health, La Trobe University, Melbourne, Australia. 6Menzies Institute for Medical Research,
University of Tasmania, Hobart, Australia. 7Physiotherapy Department, Caulfield Hospital, Alfred Health, Melbourne, Australia.
8School of Health Sciences, and Priority Research Centre for Stroke and Brain Injury, University of Newcastle, Newcastle, Australia.
9Hunter Medical Research Institute, Newcastle, Australia. 10Clinical Exercise Science Research Program, Institute of Sport, Exercise
and Active Living, Victoria University, Melbourne, Australia. 11Faculty ofMedicine andHealth Sciences,Macquarie University, Sydney,
Australia. 12School of Physiotherapy, Australian Catholic University, Brisbane, Australia. 13Discipline of Physiotherapy, Faculty of
Health, University of Canberra, Canberra, Australia. 14Melbourne; Adelaide; Newcastle; Hobart; Sydney; Brisbane; Canberra, Australia
Contact address: Elizabeth A Lynch, Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia,
Australia. elizabeth.lynch@adelaide.edu.au.
Editorial group: Cochrane Stroke Group.
Publication status and date: New, published in Issue 2, 2017.
Citation: Lynch EA, Borschmann K, Callisaya ML, Fini NA, Janssen H, Johnson L, Jones TM, Kramer S, Kuys S, Mahendran N,
Simpson DB, English C, on behalf of the ACTIOnS Collaboration. Activity monitors for increasing physical activity in adult stroke
survivors. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD012543. DOI: 10.1002/14651858.CD012543.
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To summarise the available evidence regarding the effectiveness of commercially available wearable devices and smart phone applications
for increasing physical activity levels for people with stroke.
B A C K G R O U N D
Description of the condition
Between 1990 and 2010 absolute numbers of people living with
stroke increased by 84% worldwide, and stroke is now the third
leading cause of disability globally (Feigin 2014). As such, the
disease burden of stroke is substantial. It has been estimated that
91% of the burden of stroke is attributable to modifiable risk fac-
tors such as smoking, poor diet, and low levels of physical activity
(Feigin 2016). A low level of physical activity (less than four hours
per week) is the second highest population-attributable risk factor
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for stroke, second only to hypertension (O’Donnell 2016). The
promotion of physical activity, which has been defined as body
movement produced by skeletal muscles resulting in energy ex-
penditure (Caspersen 1985), is therefore an important health in-
tervention for people with stroke.
The association between health and physical activity is well estab-
lished. Prolonged, unbroken bouts of sitting is a distinct health
risk independent of time engaged in regular exercise (Healy 2008).
There is evidence from cross-sectional and longitudinal studies
that high sitting time and low levels of physical activity contribute
to poor glycaemic control (Owen 2010). Three systematic reviews
and meta-analyses of observational studies have confirmed that,
after adjusting for other demographic and behavioural risk factors,
physical activity is inversely associated with all-cause mortality in
men and women (Nocon 2008; Löllgen 2009; Woodcock 2011).
Yet despite this knowledge, populations worldwide are becoming
more sedentary, and physical inactivity has been labelled a global
pandemic (Kohl 2012).
In addition to overcoming the sedentary lifestyles andhabits preva-
lent in many modern societies, people with stroke have additional
barriers to physical activity such as weakness, sensory dysfunc-
tion, reduced balance, and fatigue (Billinger 2014). Directly after
a stroke, people should be admitted to hospital for co-ordinated
care and commencement of rehabilitation (SUTC 2013). Early
rehabilitation after stroke is frequently focused on the recovery
of physical independence (Pollock 2014). Recovery after stroke
is enhanced by active practice of specific tasks, and greater im-
provements are seen when people with stroke spend more time in
active practice (Veerbeek 2014). Yet findings from research con-
ducted around the world indicate that people in the first fewweeks
and months after stroke are physically inactive in hospital settings
with around 80% of the day spent inactive (sitting or lying) (West
2012). These high levels of inactivity are concerning because re-
covering the ability to walk independently is an important goal of
people with stroke. The reported paucity of standing and walking
practice in the early phase after stroke potentially limits the op-
portunities of people with stroke to optimise functional recovery,
particularly for standing and walking goals. Further, physical in-
activity may lead to an increased risk of hospital-acquired compli-
cations, such as pressure ulcers, pneumonia, and cardiac compro-
mise (Lindgren 2004).
Physical activity levels of people with stroke remain lower than
their age-matched counterparts even when they return to living in
the community (English 2016). Community-dwelling stroke sur-
vivors spend the vast majority of their waking time sitting down
(English 2014). Promisingly, early research suggests that increas-
ing physical activity in people with stroke is feasible, and that an
increase in physical activity levels after stroke may have a positive
impact on fatigue, mood, community participation, and quality
of life (QoL) (Graven 2011; Duncan 2015).
Description of the intervention
For this review, we will consider an activity monitor to be any
wearable or portable electronic device that provides feedback (ei-
ther real-time or terminal) on physical activity. Activity monitors
can be used independently by people with stroke or as an adjunct
to therapy. Activity monitors include accelerometers and physical
activity applications and these may be combined with global po-
sitioning systems. Feedback from a physical activity monitor can
include objective measures of activity (e.g. step count, time spent
in moderate intensity activity), graphs of daily activity, or encour-
agement on activity goals (e.g. encouragement to reach 10,000
steps per day, or reminders to move if sitting for a defined time).
Accelerometers are non-invasive activity monitors that record ’ac-
tivity counts’ based on acceleration detected across various move-
ment planes (e.g. X, Y, Z planes). The objective measures of ac-
tivity provided by accelerometers are dependent on the individ-
ual device, and include step count, activity duration, total activity
counts, and energy expenditure. Accelerometers are classified as
’uniaxial’, ’biaxial’, or ’triaxial’ depending on the number of move-
ment planes across which they detect acceleration. Examples of ac-
celerometers include Fitbit Charge HR, Actigraph, and Sensewear
Armband.
Physical activity applications are typically installed on mobile
smart devices which contain powerful embedded sensors, includ-
ing triaxial accelerometers, global positioning system (GPS), cam-
eras, orientation sensors, and gyroscopes that can be used to de-
liver continuous and automated real-time data to measure and
interpret physical activity (Bort-Roig 2014). Applications down-
loaded on smart devices feature real-time feedback based on the
user’s activity profile, and some applications include an immersive
storyline to engage the user in physical activity (Higgins 2016). Il-
lustrations and animations are commonly used to describe how an
activity/exercise is to be correctly performed, and some devices can
be paired with wearable devices to further enhance the experience
and data generated (Higgins 2016). Examples of physical activity
applications include Strava Running, Runkeeper, and Fitbit.
GPS technology is now inbuilt into many mobile phones as well
as wearable physical activity monitors and measures activity based
on the location of the person. An example of a physical activity
GPS is Garmin Forerunner.
How the intervention might work
Activity monitors are cheap and readily available to the public.
They provide users with easy-to-understand, timely, and contextu-
ally relevant information about their physical activity behaviours.
Further,many physical activity monitors have been designed to set
goals and provide rewards, which are important elements in chang-
ing (and maintaining the change in) behaviour (Glynn 2013).
Some applications have been designed to act as ’virtual coaches’
to encourage and inspire the user. In addition, the capacity for
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the user’s behaviour to be shared via the connectivity capabilities
of smart devices can promote social support, feedback, and com-
petition via social networking platforms (Nakhasi 2014). Meta-
analyses have shown that activity monitors can positively influence
multiple health behaviours, including physical activity (Fanning
2012).
Activity monitors are increasingly being used to study physical
activity in stroke survivors (Fini 2015). Use of these devices has the
potential to be a relatively cheap and easy method of motivating
people with stroke both in the clinical and community setting
to increase physical activity levels for the purposes of maximising
post-stroke physical function (i.e. walking) and reducing the risk
of recurrent stroke (via regular exercise).
Why it is important to do this review
Despite the benefits of time spent in physical activity post-stroke,
people who have had a stroke spend the majority of their day in-
active, both during their inpatient rehabilitation (West 2012) and
once living back in the community (English 2014). Commercially
available wearable activity monitoring devices and smart phone
applications provide immediate feedback to users on their physical
activity levels, and if found to be effective in increasing physical
activity, these have the potential to benefit all people with stroke.
Understanding how effective such devices are in increasing physi-
cal activity after stroke will be useful for clinicians and researchers
working in stroke prevention and rehabilitation, and for people
with stroke who would like to improve their physical activity levels
and general well-being.
It is not yet understood whether physical activity monitors alone,
or with therapist support are effective and feasible in increasing
physical activity after stroke. Further, investigation of character-
istics of people with stroke (e.g. age, stroke severity) which may
influence a person’s ability to use an activity monitor indepen-
dently or to engage in behaviour change in response to activity
monitor feedback is required. Finally, factors related to the activity
monitor intervention, such as type of monitor, setting, duration
of intervention, intensity, dose, frequency, and mode of feedback
for optimum improvements in physical activity after stroke need
to be determined.
O B J E C T I V E S
To summarise the available evidence regarding the effectiveness of
commercially available wearable devices and smart phone applica-
tions for increasing physical activity levels for people with stroke.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) and ran-
domised cross-over trials.
Types of participants
Participants will be adults (aged 18 and over) with a diagnosis of
stroke, who are in hospital settings or living in the community.
If we identify studies with a mixed population including people
with stroke, we will contact the study’s authors and request data
from just people with stroke so their data can be included.
Types of interventions
We will include interventions that examine the effectiveness or
feasibility of the use of activity monitors for increasing physical
activity levels within hospital or community settings in the review.
We will exclude upper limb activity monitor interventions that
have been designed to increase upper limb activity.
Variations of the intervention will include the type and frequency
of feedback delivered (including whether timing was set or con-
trolled by participants), the duration of intervention, and the type
of activity monitor used.
We will include studies that compare use of:
• activity monitor versus no intervention;
• activity monitor versus other intervention;
• activity monitor versus different activity monitor
intervention;
• use of activity monitor plus other intervention (e.g. a
prescribed exercise program) versus other intervention alone.
We will exclude studies which compare use of activity monitor
plus other intervention versus no treatment, when the effect of
the activity monitor intervention cannot be determined. As our
intention is to include studies that use physical activitymonitors to
promote physical activity, wewill exclude studies when the activity
monitor is used solely as a measurement tool.
Types of outcome measures
Primary outcomes
• Steps per day. Steps per day is relevant to people with stroke
because it is associated with Activities and Participation domains
of the International Classification of Functioning (Eng 2007).
• Time spent in moderate-vigorous physical activity (MVPA)
at the end of the intervention period (short term), three months’
post-intervention (medium term), and 12 months’ post-
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intervention (long term). We will measure time in MVPA in
minutes per day and percentage of waking hours. We will
include two methods of calculating MVPA with devices:
◦ using metabolic equivalents (METS): 3 METS or
greater, where 1 MET is defined as the energy cost of sitting
quietly (Haskell 2007);
◦ using activity count cut-off points: for example, 1952
counts per minute or greater (using the equations from Freedson
and colleagues) (Freedson 1998).
Time in MVPA is important because MVPA has a vital role in the
prevention of cardiovascular disease and stroke (Tremblay 2010;
McDonnell 2013; Billinger 2014). Further, MVPA is inversely as-
sociated with all-cause mortality in men and women, after adjust-
ment for other demographic and behavioural risk factors (Nocon
2008; Löllgen 2009; Woodcock 2011). Achieving a total physical
activity level of 150 minutes per week of MVPA has been asso-
ciated with a relative risk reduction (RRR) in all-cause mortality
of 16%, and a RRR of 26% was reported for the higher thresh-
old of 300 minutes of MVPA per week (Samitz 2011). Current
guidelines recommend that stroke survivors complete at least 150
minutes per week of at least moderate-intensity physical activity
(Billinger 2014).
Secondary outcomes
We will include further objective measures of physical activity as
secondary outcomes.
• Sedentary time (measured in minutes per day and
percentage of waking hours).
• Time spent in light physical activity (measured in minutes
per day and percentage of waking hours).
• Walking duration (measured in minutes per day and
percentage of waking hours).
These measures can assist in providing a complete picture of phys-
ical activity and include measures of intensity, frequency, and du-
ration (Fini 2015).
We will also include self-reportedmeasures of physical activity lev-
els as secondary outcomes in terms of type of activity and context
in which activity is undertaken.
We will include other measures as secondary outcomes.
• Fatigue (if a trial used multiple fatigue outcome measures,
we will include the main outcome measure as specified by trial
investigators. Where trial investigators have not specified the
main outcome, priority will be given to Fatigue Assessment Scale
and Fatigue Severity Scale).
• Mood (e.g. Hospital Anxiety and Depression Scale, General
Health Questionnaire 12 Item, Brief Assessment Schedule
Depression Cards, Patient Health Questionnaire 9 items).
• Quality of life (QoL) (e.g. Stroke Specific Quality of Life
Scale, Stroke Impact Scale-16, EuroQol).
• Community participation (e.g. World Health Organization
(WHO) Disability Assessment Schedule).
• Adverse events such as falls and hospitalisations.
• Death.
Fatigue, mood, community participation, and QoL are altered
following stroke (Hackett 2005; Graven 2011; Duncan 2015),
and an increase in physical activity may have a positive impact on
these factors (Graven 2011; Duncan 2015).
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module. We will search for trials in all languages and arrange for
the translation of relevant articles where necessary.
Electronic searches
We will search the following databases:
• Cochrane Stroke Group Trials Register (most recently
updated);
• Cochrane Central Register of Controlled Trials
(CENTRAL) (latest issue);
• MEDLINE (Ovid) (from 1946) (Appendix 1);
• Embase (Ovid) (from 1980);
• CINAHL (EBSCO) (from 1982);
• SPORTDiscus (EBSCO) (from 1949).
We developed the MEDLINE search strategy with the help of
the Cochrane Stroke Group Information Specialist, which will be
adapted for the other databases as necessary (Appendix 1).We will
not limit searches to any language or type of publication.
Additionally, we will search the following ongoing trials registers:
• WHO International Clinical Trials Registry Platform (
www.who.int/ictrp/en/);
• Clinicaltrials.gov (www.clinicaltrials.gov);
• EU Clinical Trial Register (www.clinicaltrialsregister.eu);
• ISRCTN Registry (www.isrctn.com);
• Australian and New Zealand Clinical Trial Registry (
www.anzctr.org.au);
• Stroke Trials Registry (www.strokecenter.org/trials).
Searching other resources
To identify any further published, unpublished, or ongoing trials
successfully, we will:
• search the reference lists of relevant articles and use the Web
of Science cited reference search for forward tracking of
references;
• search Google Scholar (scholar.google.com);
• attempt to contact trial authors to obtain further data if
required.
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Data collection and analysis
Selection of studies
Two or more review authors (HJ, NF, DS) will independently
screen titles and abstracts of the references obtained as a result of
our searching activities and will exclude obviously irrelevant re-
ports. We will retrieve the full-text articles for the remaining refer-
ences and two or more review authors (HJ, NF, DS) will indepen-
dently screen the full-text articles and identify studies for inclu-
sion, and identify and record reasons for exclusion of the ineligible
studies. We will resolve any disagreements through discussion or,
if required, we will consult a fourth review author (LJ). We will
collate multiple reports of the same study so that each study, not
each reference, is the unit of interest in the review. We will record
the selection process and complete a PRISMA flow diagram.
Data extraction and management
Two or more review authors (NF, DS, KB) will independently
extract data from included studies and record this information
on a data extraction form developed specifically for this study.
We will pilot the data extraction form on three studies to ensure
clarity and comprehensiveness of data collection. We will extract
the following data: type of study, participant population, study
setting, details of interventions and co-interventions, time frame,
and details of outcomes and their definitions. Wewill use headings
from the TIDieR checklist to guide extraction of data regarding
the interventions and co-interventions (Hoffmann 2014).We will
compare the extracted results and will resolve any discrepancies by
discussion.
Assessment of risk of bias in included studies
Two or more review authors (SKr, LJ, DS) will independently
assess risk of bias for each study using the criteria outlined in
the Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2011). We will resolve any disagreements by discussion
or by involving a fourth review author (EL). We will assess the risk
of bias according to the following domains.
• Random sequence generation.
• Allocation concealment.
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete outcome data.
• Selective outcome reporting.
• Other bias (e.g. carryover bias in cross-over trials,
contamination between groups).
We will grade the risk of bias for each domain as high, low, or
unclear. Low risk of bias indicates the study appears to be free from
bias for the domain. We will grade a domain as having an unclear
risk of bias when there is a risk of bias but there is insufficient
information available to determine whether an important risk of
bias is present, or there is a lack of clarity whether an identified
problem will introduce bias. When there is at least one important
risk of bias for a domain, we will identify the domain as having a
high risk of bias. We will report information for each domain for
each study together with a justification for our judgement in the
’Risk of bias’ tables.
Measures of treatment effect
We will express continuous data as mean differences (MDs) with
95% confidence intervals (CIs) for data measured in the same
way between trials, or standardised mean differences (SMDs) with
95%CIs to combine data when different scales were used for mea-
surement. We will express dichotomous data as risk ratios (RRs)
with 95% CI.
Unit of analysis issues
We will include all studies or trials with cluster-randomisation as
well as individually randomised trials. We will determine whether
or not to combine the results of individual RCTs and cluster-RCTs
by performing a subgroup analysis separating individual RCTs and
cluster-RCTs. If there is no significant difference between the re-
sults of the individual RCTs and cluster-RCTs, as indicated by a
non-statistically significant result in the test of subgroup differ-
ence, we will consider it reasonable to combine the results from
all included studies. We will include cross-over trials in the review
and use only data from the first phase of included trials.
Dealing with missing data
We will follow the methods for sensitivity analysis described in
the Cochrane Handbook for Systematic Reviews of Interventions for
dealing with missing data (Higgins 2011). We will assess and re-
port the dropout rates of each study, and use the principle of in-
tention-to-treat analyses whereby we will analyse all participants
according to group allocation. We will contact study authors to
request data in an appropriate format to enable data syntheses and
meta-analyses if such data are not reported in the retrieved paper.
We will consider missing data as part of the assessment of risk of
bias within included studies.
Assessment of heterogeneity
We will visually inspect the forest plots for any evidence of het-
erogeneity. We will use the I2 statistic to measure heterogeneity
among the trials in each analysis, with an I2 statistic of 50% or
higher indicating moderate to substantial heterogeneity. Due to
the wide variety of devices considered and the broad eligibility
criteria set for participants, we will use a random-effects model.
5Activity monitors for increasing physical activity in adult stroke survivors (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Assessment of reporting biases
We will use funnel plots to detect reporting biases (such as publi-
cation bias). We will assess funnel plot asymmetry visually.
Data synthesis
Where we consider two or more studies to be similar in terms
of participant population and intervention received, we will con-
duct a meta-analysis by pooling the appropriate data using Review
Manager 5 (RevMan 2014). We will describe findings narratively
when studies do not allow for data to be pooled.
Subgroup analysis and investigation of heterogeneity
We intend to explore heterogeneity by additional subgroup anal-
ysis if data are available.
• Setting (hospital or community).
• Type of activity monitor (similar pedometer versus more
complex body worn activity monitor).
• Frequency of feedback (real time versus terminal).
• Participant-specific factors (to facilitate identification of
people with stroke most likely to respond to activity monitor
interventions):
◦ age 18 to 64 years, 65 years and over;
◦ walking ability (independent or requiring assistance);
◦ time since stroke (within one month, between one and
six months, more than six months);
◦ gait speed;
◦ gait endurance.
Sensitivity analysis
We will judge study methods using Cochrane’s tool for assessing
risk of bias (Higgins 2011). We will perform sensitivity analyses
to assess the robustness of the findings by excluding the studies
from the analysis which are at high risk of bias .
’Summary of findings’ table
We will create a ’Summary of findings’ table including the fol-
lowing outcomes (steps per day, time spent in MVPA, sedentary
time, time spent in light physical activity, walking duration, and
adverse events). Two or more review authors (NF, DS, KB) will
independently rate the quality of evidence regarding the studies
that contribute data to the meta-analyses for each outcome us-
ing the GRADE approach (www.gradeworkinggroup.org/) and
the GRADEproGuideline Development Tool (GRADEproGDT
2015). We will provide footnotes or comments to justify all de-
cisions to downgrade or upgrade the quality of studies. If meta-
analysis is not possible, we will present results in a narrative ’Sum-
mary of findings’ table format.
An empty ’Summary of findings’ table for our first comparison
(physical activity intervention versus no treatment) is provided
below. When more than one study is included for the other com-
parisons (physical activity monitor intervention versus other treat-
ment, physical activity monitor intervention versus different ac-
tivity monitor intervention, and physical activity monitor inter-
vention plus other intervention versus other intervention alone),
we will add relevant sections to the ’Summary of findings’ table.
Population: people with stroke
Settings: hospital, community or home setting
Intervention: physical activity monitor intervention
Comparison: no treatment
Outcomes Illustrative comparative risks
(95% CI)
Relative effect
(95% CI)
No of partici-
pants (studies)
Certainty of the
evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
No treatment Physical activ-
ity monitor in-
tervention
Steps per day - - - - - -
Time in MVPA - - - - - -
Sedentary time - - - - - -
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(Continued)
Time in light
physical activity
- - - - - -
Walking
duration
- - - - - -
Adverse events - - - - - -
CI: confidence interval; MVPA: moderate-vigorous physical ac-
tivity.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (Ovid) search strategy
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial
hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying)
adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj
5 (h?emorrhag$ or h?ematoma$ or bleed$)).tw. 5. hemiplegia/ or exp paresis/ or exp Gait Disorders, Neurologic/
6. (hemipleg$ or hemipar$ or paresis or paraparesis or paretic).tw.
7. or/1-6
8. feedback/ or exp feedback, physiological/ or feedback, sensory/
9. monitoring, physiologic/ or exp monitoring, ambulatory/
10. exp accelerometry/ or actigraphy/
11. ((physical or physiolog$ or perform$ or fit$ or train$ or activ$ or endur$ or exercise) adj3 (track$ or monitor$ or measur$ or
device$ or app$)).tw.
12. ((step$ or walk$) adj3 (count$ or meter$ or daily)).tw.
13. (pedometer$ or actigraph$ or acceleromet$).tw.
14. telemedicine/
15. Mobile Applications/ or cell phones/ or smartphone/or exp Computers, Handheld/
16. ((cell$ or smart$ or mobile or android or internet or web) adj3 (comput$ or device or app$ or phone)).tw.
17. or/8-16
18. Randomized Controlled Trials as Topic/
19. Random Allocation/
20. Controlled Clinical Trials as Topic/
21. control groups/
22. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or
clinical trials, phase iv as topic/
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23. double-blind method/
24. single-blind method/
25. Placebos/
26. placebo effect/
27. cross-over studies/
28. randomized controlled trial.pt.
29. controlled clinical trial.pt.
30. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
31. (random$ or RCT or RCTs).tw.
32. (controlled adj5 (trial$ or stud$)).tw.
33. (clinical$ adj5 trial$).tw.
34. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
35. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
36. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
37. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
38. (cross-over or cross over or crossover).tw.
39. (placebo$ or sham).tw.
40. trial.ti.
41. (assign$ or allocat$).tw.
42. controls.tw.
43. or/18-42
44. 7 and 17 and 43
Appendix 2. Trial register search strategy
1. Stroke AND “activity monitor”
2. Stroke AND “mobile phone”
3. Stroke AND “app”
C O N T R I B U T I O N S O F A U T H O R S
EL drafted the ’Background’ and ’Description of the condition’ sections, and co-ordinated review team.
TJ, LJ, and NM drafted the ’Description of the intervention’ and ’How the intervention might work’ sections.
HJ drafted the ’Why it is important to do this review’ section.
EL and HJ the drafted ’Types of studies’, ’Types of participants’, and ’Types of interventions’ sections.
NF and KB drafted the ’Types of outcome measures’ section.
SKr developed search strategy.
SKu and CE drafted the ’Measures of treatment effect’, ’Unit of analysis issues’, and ’Dealing with missing data’ sections.
MC drafted ’Assessment of reporting biases’ and ’Sensitivity analysis’ sections.
DS drafted ’Subgroup analysis and investigation of heterogeneity’ section.
CE, SKu, HJ, MC, NF, EL, and DS conceptualised the review.
All authors read and reviewed the completed draft.
10Activity monitors for increasing physical activity in adult stroke survivors (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D E C L A R A T I O N S O F I N T E R E S T
EL: none known.
KB: none known.
MC: none known.
NF: none known.
HJ: none known.
LJ: none known.
TJ: none known.
SKr: none known.
SKu: none known.
NM: none known.
DS: none known.
CE: none known.
11Activity monitors for increasing physical activity in adult stroke survivors (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
